Clinical Trials Browser

Unknown × Adenocarcinoma of Lung × Bevacizumab × Clear all

NCT05675033 2023-01-09

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma

Phase 2 Unknown

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT03905317 2019-04-05

Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver Gene

Phase 2 Unknown

Adenocarcinoma of Lung